Delivery Order SPE2DB20D3103-SPE2DB24FN2A4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.74 firm fixed-price delivery order is for the supply of 20,000 units/mL of the medication PROCRIT. The contract has an ultimate completion date of January 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,841.54 firm fixed-price delivery order is for the supply of 10,000 units/ml of the medication PROCRIT. This award is not associated with any set-aside program. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 30, 2022. The $6,327.14 firm fixed-price delivery order is for the supply of 40,000 units/mL of the drug PROCRIT. The contract has a completion date of December 1, 2022 and is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,575.16 firm-fixed-price delivery order is for the supply of 10,000 units/ml vials of PROCRIT, a medication, with an ultimate completion date of April 22, 2024. The contract is not associated with a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,592.84 firm fixed-price contract is for the delivery of 40,000 units of the medication PROCRIT, a treatment for anemia, to fulfill federal medical supply requirements. The contract has a completion date of June 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,488.38 firm fixed price delivery order is for the supply of 20,000 units of PROCRIT 20,000 units/mL vials. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,991.78 firm-fixed-price delivery order is for the supply of 40,000 units of the drug Procrit (40,000 units/mL) and does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the Defense Logistics Agency (DLA) Troop Support Medical with PROCRIT 10,000 units/mL vials (2 mL). The $2,664.16 firm fixed-price delivery order is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a key mechanism for providing a comprehensive range of pharmaceutical products and medical...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,666.43 contract is for the delivery of 40,000 units/mL vials of the pharmaceutical product PROCRIT. The delivery order has a completion date of January 24, 2024 and was awarded on January 23, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN2A4Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,288.54 firm fixed-price contract is for the delivery of 40,000 units/mL of the drug PROCRIT, with a completion date of March 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award appears to be a task order under that overarching IDC. No set-aside designation is indicated, suggesting open competition for this procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 3/27/24 |